Equity Details
Price & Market Data
Price: $1.61
Daily Change: +$0.10 / 6.21%
Daily Range: $1.50 - $1.66
Market Cap: $4,764,745
Daily Volume: 46,184
Performance Metrics
1 Week: -5.45%
1 Month: -19.63%
3 Months: -48.68%
6 Months: -36.84%
1 Year: -63.80%
YTD: -44.08%
About Cardio Diagnostics Holdings, Inc. (CDIO)
Stay ahead with market insights for Cardio Diagnostics Holdings, Inc. (CDIO). The stock is currently at 1.61, having moved by +$0.10 / 6.21% today. Its impressive market capitalization is 4,764,745. Find out how it has performed year-to-date and over 1, 3, 6, and 12 months.
Company Details
Employees: 15
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
